Clinical Trials Directory

Trials / Sponsors / Summit Therapeutics

Summit Therapeutics

Industry · 11 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingPhase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Canc
Metastatic Colorectal Cancer (CRC)
Phase 32025-11-18
RecruitingClinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Non-Small Cell Lung Cancer
Phase 32025-02-27
RecruitingClinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Non-Small Cell Lung Cancer
Phase 32023-10-26
Active Not RecruitingPhase III Study of AK112 for NSCLC Patients
Non-Squamous Non-small Cell Lung Cancer
Phase 32023-05-04
TerminatedSafety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects
Clostridioides Difficile Infection
Phase 32021-05-19
CompletedComparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
Clostridioides Difficile Infection
Phase 32019-01-28
TerminatedProof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular D
Duchenne Muscular Dystrophy
Phase 22016-06-01
CompletedModified Diet Trial: A Study of SMT C1100 in Paediatric Patients With DMD Who Follow a Balanced Diet
Muscular Dystrophy, Duchenne
Phase 12015-02-01
CompletedA Study of Ridinilazole (SMT19969) Compared With Fidaxomicin for the Treatment of Clostridium Difficile Infect
Clostridium Difficile Infection
Phase 22014-12-01
CompletedA Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (
Clostridium Difficile Infection
Phase 22014-04-01
CompletedA Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD)
Duchenne Muscular Dystrophy
Phase 12013-11-01